Showing results (971-980 of 3,833) with videos related to

Sort By:
Pageof 384
The Japanese Journal of Antibiotics|October 1, 1990
[Detection of causative bacteria for bovine mastitis and their susceptibility to beta-lactam antibacterial agents]S Kamata, T Matsunaga, K Uchida, et al.
The Japanese Journal of Antibiotics|October 1, 1990
[Combination therapy with aztreonam and clindamycin on severe infections accompanying neutropenic patients with hematological disorders]A Urabe, F Takaku, H Mizoguchi, et al.
The Japanese Journal of Antibiotics|October 1, 1990
[Susceptibilities of clinical bacterial isolates to antimicrobial agents. A study mainly focused on imipenem. Research Group for Testing Imipenem Susceptibility on Clinical Isolates]J Igari
The Japanese Journal of Antibiotics|October 1, 1990
[Pharmacokinetic and clinical studies on cefdinir fine granules in children]S Nakata, S Chiba
The Japanese Journal of Antibiotics|October 6, 2010
[Clinical application of azithromycin extended-release (ER) formulation to treat female sexually transmitted infection]Michinori Terada, Emiko Ohki, Yuka Yamagishi, et al.
The Japanese Journal of Antibiotics|October 28, 2010
[Clinical implication of therapeutic drug monitoring on voriconazole from the aspect of the analysis for CYP2C19 gene]Masao Kimura, Yuka Yamagishi, Noriyo Kawasumi, et al.
The Japanese Journal of Antibiotics|April 1, 1990
[Studies on aztreonam in the perinatal period]N Cho, K Fukunaga, K Kunii, et al.
The Japanese Journal of Antibiotics|February 9, 2011
[Evaluation of the safety and efficacy of cefditoren pivoxil fine granules for pediatric use in pediatric patients with laryngopharyngitis and tonsillitis caused by Streptococcus pyogenes]Saori Kawamata, Hitoshi Yamada, Yoshikazu Sato, et al.
The Japanese Journal of Antibiotics|February 1, 1985
[Experimental and clinical evaluation of the BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field]T Shinozaki, H Meguro, R Fujii, et al.
The Japanese Journal of Antibiotics|February 1, 1985
[Laboratory and clinical studies of BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field]T Nishimura, K Tabuki, T Takashima, et al.
Pageof 384